Trial intelligence / Profile preview

PK Study of Naftifine (NAFT-500/600) in Pediatric Tinea Pedis and Cruris

NCT01712360Phase 4Completed

Sponsor
Merz
Start
Oct 2012
Primary completion
Nov 2013
Modality
Orthosteric Ligands
Countries
3
01

Overview

A Phase 4 trial of naftifine in tinea pedis, Tinea cruris (TC), sponsored by Merz. Started Oct 2012; status: completed.

02

Drugs

naftifine
03

Conditions

tinea pedisTinea cruris (TC)

Beyond the preview

Go deeper on NCT01712360.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01712360.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call